Lakeside Holding

Lakeside Holding Limited
Company typePublic
NasdaqLSH
IndustryLogistics
Founded2018
HeadquartersItasca, Illinois, U.S
Key people
Henry Liu (CEO)
Shuai Li (COO)
RevenueIncrease US$4.08 million (2024)
Increase US$0.24 million (2024)
Number of employees
50+ (2024)
Websitelakeside-holding.com

Lakeside Holding Limited (Nasdaq: LSH) is a U.S.-based integrated cross-border supply chain solution provider with a strategic focus on the Asian market, including China and South Korea. Operating under the brand American Bear Logistics, the company offers customized cross-border ocean and air freight solutions tailored to clients' needs for transporting goods into the United States.

History

Lakeside Holding Limited was founded in 2018 and is headquartered in Itasca, Illinois. The company has established itself in the logistics industry by providing services to logistics companies serving e-commerce platforms, social commerce platforms, and manufacturers. It is Asian American-owned and leverages an in-depth understanding of both U.S. and Asian international trading and logistics service markets.

Services

The company specializes in:

  • Cross-border freight consolidation and forwarding
  • Customs clearance
  • Warehousing and distribution
  • Domestic ground transportation

These services cater to the transportation of consumer and industrial goods from Asia to the U.S., addressing specific client requirements.

Initial Public Offering (IPO)

On June 28, 2024, Lakeside Holding Limited commenced trading on the Nasdaq Capital Market under the ticker symbol "LSH". The company offered 1.5 million shares at a public offering price of $4.50 per share, resulting in total gross proceeds of $6.75 million before underwriting discounts and offering expenses.[1]

Recent Developments

In November 2024, Lakeside Holding Limited expanded into the medical logistics sector by acquiring Hupan Pharmaceutical (Hubei) Co., Ltd., a comprehensive pharmaceutical distribution and supply chain service provider based in Wuhan, China.[2] The acquisition is projected to add approximately $7 million in annual revenue.

Following the acquisition of Hupan Pharmaceutical, the company entered a partnership with Sinopharm Hubei, a subsidiary of Sinopharm Group Co., Ltd.[3] This collaboration aims to support comprehensive pharmaceutical distribution needs, highlighting the growing demand for specialized logistics and supply chain solutions in China's healthcare market.

Financial Performance

For the first quarter of fiscal year 2025, ending September 30, 2024, Lakeside reported total revenues of $4,081,554.[4] This represented a slight decrease compared to the same period in the previous year, primarily due to a reduction in revenues from cross-border airfreight solutions, partially offset by an increase in cross-border ocean freight solutions.[5][6][7][8][9]

References

  1. ^ "Lakeside Holding Limited Announces Closing of Upsized $6.75 Million Initial Public Offering". nasdaq.com. 2024-07-01. Retrieved 2024-11-28.
  2. ^ "Lakeside Holding Enters Medical Logistics Sector with Acquisition of Hupan Pharmaceutical (Hubei) Co., Ltd". prnewswire.com. Retrieved 2024-11-28.
  3. ^ "Lakeside Strengthens Market Position in China's Pharmaceutical Logistics with Key Sinopharm (Hubei) Contracts". www.taiwannews.com.tw. Retrieved 2024-11-28.
  4. ^ "LAKESIDE HOLDING PROVIDES FIRST QUARTER OF FISCAL YEAR 2025 RESULTS". prnewswire.com. Retrieved 2024-11-28.
  5. ^ "Lakeside Holding Limited (LSH) Company Information". Stock Analysis. Retrieved 2024-11-28.
  6. ^ "Lakeside Holding Limited (LSH) on Yahoo Finance". finance.yahoo.com.
  7. ^ "Check out Lakeside Holdings Ltd's stock price (LSH) in real time". CNBC. Retrieved 2024-12-02.
  8. ^ "Lakeside Holding Ltd. | IPOScoop". Retrieved 2024-12-03.
  9. ^ "Lakeside Holding Ltd - Company Profile and News". Bloomberg.com. Retrieved 2024-12-03.